ADD CONDITION
Fenbendazole
Last content change checked dailysee data sync status
- Active ingredient
- Fenbendazole 1 kg/1 kg
- Other brand names
- Defendazole (by Norbrook Laboratories Limited)
- Fenbendazole (by Letco Medical, Llc)
- Fenbenpro Purity and Precision Fenbendazole (by Hubihol, Uab)
- Fenbenpro Purity and Precision Fenbendazole (by Hubihol, Uab)
- Panacur (by Merck Sharp & Dohme Corp.)
- Panacur (by Merck Sharp & Dohme Corp.)
- Panacur (by Merck Sharp & Dohme Corp.)
- Panacur (by Merck Sharp & Dohme Corp.)
- Panacur C Canine (by Merck Sharp & Dohme Corp.)
- Safe-Guard (by Merck Sharp & Dohme Corp.)
- Safe-Guard (by Merck Sharp & Dohme Corp.)
- Safe-Guard (by Merck Sharp & Dohme Corp.)
- Safe-Guard (by Merck Sharp & Dohme Corp.)
- Safe-Guard (by Merck Sharp & Dohme Corp.)
- Safe-Guard Aquasol (by Merck Sharp & Dohme Corp.)
- View full label-group details →
- Dosage form
- Powder
- Prescription status
- Animal
- Pregnancy
- See Pregnancy Use Section
- Lactation
- See Lactation Use Section
- Marketed in the U.S.
- Since 2024
- Label revision date
- February 23, 2026
- Veterinary Document
- Prescribing information, PDF file
- Active ingredient
- Fenbendazole 1 kg/1 kg
- Other brand names
- Defendazole (by Norbrook Laboratories Limited)
- Fenbendazole (by Letco Medical, Llc)
- Fenbenpro Purity and Precision Fenbendazole (by Hubihol, Uab)
- Fenbenpro Purity and Precision Fenbendazole (by Hubihol, Uab)
- Panacur (by Merck Sharp & Dohme Corp.)
- Panacur (by Merck Sharp & Dohme Corp.)
- Panacur (by Merck Sharp & Dohme Corp.)
- Panacur (by Merck Sharp & Dohme Corp.)
- Panacur C Canine (by Merck Sharp & Dohme Corp.)
- Safe-Guard (by Merck Sharp & Dohme Corp.)
- Safe-Guard (by Merck Sharp & Dohme Corp.)
- Safe-Guard (by Merck Sharp & Dohme Corp.)
- Safe-Guard (by Merck Sharp & Dohme Corp.)
- Safe-Guard (by Merck Sharp & Dohme Corp.)
- Safe-Guard Aquasol (by Merck Sharp & Dohme Corp.)
- View full label-group details →
- Dosage form
- Powder
- Prescription status
- Animal
- CSA schedule
- Not a scheduled drug
- Pregnancy
- See Pregnancy Use Section
- Lactation
- See Lactation Use Section
- Marketed in the U.S.
- Since 2024
- Label revision date
- February 23, 2026
- Manufacturer
- AMGIS LIFESCIENCE LIMITED
- NDC root
- 84187-020
- Veterinary Document
- Prescribing information, PDF file
If you are a healthcare professional or from the pharmaceutical industry please visit this version.
If you are a consumer or patient please visit this version.
Drug Overview
Fenbendazole is a medication primarily used to treat parasitic infections in animals, particularly in dogs and cats. It works by targeting and eliminating various types of worms and other parasites that can affect your pet's health. While the specific details of its mechanism of action are not provided, fenbendazole is known for its effectiveness in managing these infections, helping to ensure your pet remains healthy and free from harmful parasites.
Uses
It seems that the information provided does not specify any particular species or conditions/diseases that the drug treats or prevents. Without these details, I cannot provide you with specific uses for the medication. If you have more information or a different list of uses, please share it, and I would be happy to help you rewrite that content for a general audience.
Dosage and Administration
Fenbendazole comes in several sizes to suit your needs, available in drums of 1 kg, 5 kg, 10 kg, and 25 kg. This allows you to choose the right amount based on your specific requirements.
While the exact method of taking or applying fenbendazole isn't detailed, it's important to follow any instructions provided by your healthcare professional or the product label. Make sure to consult with them for guidance on how often you should use it to ensure you get the best results.
What to Avoid
You can feel confident using this medication, as there are no specific contraindications, controlled substance classifications, or concerns regarding abuse, misuse, or dependence associated with it. This means that, based on the available information, there are no known reasons to avoid taking this medication. Always remember to follow your healthcare provider's guidance and reach out if you have any questions or concerns about your treatment.
Side Effects
You may be relieved to know that there are no common or serious side effects associated with this medication. Additionally, there are no reported allergic reactions or issues related to the cardiovascular, neurological, or dermatologic systems. Overall, the safety profile appears to be very favorable, with no adverse reactions noted in postmarketing experiences or other important notes.
Warnings and Precautions
While there are no specific warnings or precautions associated with this medication, it's always important to stay informed about your health. If you experience any unusual symptoms or have concerns while using this medication, it's a good idea to consult your doctor for guidance.
Currently, there are no laboratory tests required for safe use of this medication, which simplifies your experience. However, if you ever feel uncertain or have questions about your treatment, don't hesitate to reach out to your healthcare provider for support.
Overdose
It appears that there is no specific information available regarding overdosage for this medication. However, it's important to be aware of the general signs of an overdose, which can include symptoms like extreme drowsiness, confusion, or difficulty breathing. If you suspect that you or someone else may have taken too much of a medication, it’s crucial to seek immediate medical help.
In case of an overdose, you should contact your local emergency services or go to the nearest hospital right away. Always keep the medication packaging on hand, as it can provide important information to healthcare professionals. Remember, when in doubt, it’s better to err on the side of caution and seek help.
Pregnancy Use
If you are pregnant or planning to become pregnant, it's important to know that there is no available information about the use of fenbendazole during pregnancy. This means that safety concerns, dosage adjustments, or any special precautions related to its use in pregnant individuals have not been established.
Given this lack of information, it is advisable to consult with your healthcare provider before using fenbendazole or any medication during pregnancy to ensure the safety of both you and your baby.
Lactation Use
If you are breastfeeding or planning to breastfeed, it's important to know that there is no specific information available about the use of Fenbendazole during lactation (the period of breastfeeding). This means that the effects of this medication on breast milk and nursing infants are not well-studied or documented.
As a precaution, you may want to consult your healthcare provider to discuss any potential risks and to explore alternative options if necessary. Your health and the health of your baby are the top priorities, so getting personalized advice is always a good step.
Pediatric Use
When it comes to using fenbendazole in children, it's important to note that its safety and effectiveness have not been established. This means that there isn't enough information to confirm that it is safe or works well for kids. If you are considering this medication for a child, you should consult a veterinarian. They can provide guidance on the appropriate dosage and any safety concerns you should be aware of. Always prioritize your child's health by seeking professional advice before administering any medication.
Geriatric Use
When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult, it’s important to consult with a healthcare provider for personalized advice. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.
Renal Impairment
If you have kidney problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the usual recommendations for monitoring or safety considerations related to renal impairment (kidney issues) are not provided.
Always consult your healthcare provider for personalized advice and to ensure that any medications you take are safe and appropriate for your kidney health. They can help you understand how your condition may affect your treatment plan.
Hepatic Impairment
If you have liver problems, it's important to know that the drug insert for Fenbendazole does not provide specific information about dosage adjustments, special monitoring, or precautions for patients with hepatic impairment (liver problems). This means that there are no established guidelines for how this medication should be used if you have liver issues.
Before starting Fenbendazole, you should discuss your liver health with your healthcare provider to ensure it is safe for you. They can help determine the best course of action based on your individual health needs.
Drug Interactions
It's important to have open conversations with your healthcare provider about any medications or tests you may be taking. While there are no specific drug interactions or laboratory test interactions noted for this medication, your healthcare provider can help ensure that everything you are taking works well together and is safe for you.
Always feel free to ask questions and share your complete list of medications and any lab tests you may be undergoing. This way, you can receive the best possible care tailored to your needs.
Storage and Handling
To ensure the best performance and safety of your product, store it in a cool, dry place away from direct light. It's important to keep the container tightly closed when not in use to prevent contamination. Avoid freezing the product, as this can affect its effectiveness. After opening, remember to discard any unused portion to maintain safety and quality. Following these guidelines will help you use the product safely and effectively.
Additional Information
No further information is available.
FAQ
What is Fenbendazole?
Fenbendazole is a medication used for treating certain conditions, although specific details about its uses are not provided.
What are the available strengths and packaging for Fenbendazole?
Fenbendazole is available in strengths of 1 kg, 5 kg, 10 kg, and 25 kg, each packaged in a drum.
Are there any contraindications for Fenbendazole?
No contraindications are listed for Fenbendazole.
What are the common and serious side effects of Fenbendazole?
There are no common or serious side effects listed for Fenbendazole.
Is Fenbendazole safe for pediatric use?
Pediatric use of Fenbendazole has not been established, and safety and effectiveness in children have not been determined.
What should I do if I have kidney or liver problems?
There is no specific information regarding dosage adjustments or safety considerations for patients with kidney or liver problems provided in the text.
How should I store Fenbendazole?
Store Fenbendazole in a cool, dry place, protect it from light, keep the container tightly closed when not in use, and do not freeze.
What should I do with unused Fenbendazole?
Discard any unused portion of Fenbendazole after opening.
Packaging Info
The table below lists each NDC Code for Fenbendazole veterinary formulations. Columns show Packaging, Formulation Type, and Active Ingredient Strength.
Details | ||||
|---|---|---|---|---|
| Powder | 1 kg/1 kg | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
| ||||
| Powder | 1 kg/1 kg | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
| ||||
| Powder | 1 kg/1 kg | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
| ||||
| Powder | 1 kg/1 kg | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
| ||||
Drug Information (PDF)
This PDF provides official product information for Fenbendazole, which is intended for animal use only.
Description
No description information is available for the specified drug.
Uses and Indications
This drug is indicated for the treatment and prevention of conditions and diseases as determined by healthcare professionals. Specific species and conditions are not detailed in the available information.
Healthcare providers are advised to assess the individual needs of patients to determine the appropriate use of this drug. Further guidance on usage instructions should be obtained from relevant clinical guidelines or product literature.
Dosage and Administration
Fenbendazole is available in various strengths and packaging options, including 1 kg, 5 kg, 10 kg, and 25 kg, each supplied in a drum.
The specific route, method, and frequency of administration have not been detailed in the provided information. Healthcare professionals are advised to refer to established guidelines or consult relevant literature for appropriate administration techniques and dosing intervals based on the intended use and patient population.
Contraindications
There are no contraindications associated with the use of this product. It is deemed safe for use in the absence of specific conditions or situations that would warrant avoidance.
Warnings and Precautions
Healthcare professionals should be aware that there are currently no specific warnings or general precautions associated with the use of this product. Additionally, there are no laboratory tests required or suggested for safe use.
In the absence of specific instructions regarding emergency medical assistance or recommendations to discontinue use and consult a physician, it is essential for healthcare providers to exercise clinical judgment and monitor patients as necessary based on individual circumstances and clinical presentation.
Side Effects
In clinical trials and postmarketing experiences, no common adverse reactions, serious side effects, allergic reactions, or any other notable adverse reactions have been reported. This includes categories such as cardiovascular, neurological, and dermatologic reactions, all of which have shown no documented occurrences. Additionally, there are no relevant findings from postmarketing experiences to report.
Drug Interactions
There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.
Packaging & NDC
The table below lists each NDC Code for Fenbendazole veterinary formulations. Columns show Packaging, Formulation Type, and Active Ingredient Strength.
Details | ||||
|---|---|---|---|---|
| Powder | 1 kg/1 kg | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
| ||||
| Powder | 1 kg/1 kg | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
| ||||
| Powder | 1 kg/1 kg | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
| ||||
| Powder | 1 kg/1 kg | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
| ||||
Pediatric Use
Pediatric use of fenbendazole has not been established, and the safety and effectiveness in pediatric patients remain undetermined. Healthcare professionals are advised to consult a veterinarian for appropriate dosing and safety considerations when considering fenbendazole for children.
Geriatric Use
Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.
Pregnancy
There is currently no information available regarding the use of fenbendazole during pregnancy, including safety concerns, dosage modifications, or any special precautions that should be taken. Healthcare professionals should exercise caution when prescribing fenbendazole to pregnant patients, as the potential effects on fetal outcomes are not well characterized. It is advisable to weigh the benefits against any potential risks when considering treatment options for women of childbearing potential.
Lactation
There is no information available regarding the use of Fenbendazole in nursing mothers or its effects on lactation. Consequently, the safety and efficacy of Fenbendazole in lactating mothers and its potential impact on breastfed infants remain undetermined. Healthcare professionals should exercise caution and consider the lack of data when advising lactating mothers on the use of this medication.
Renal Impairment
Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.
Hepatic Impairment
Patients with hepatic impairment have not been specifically studied in relation to the use of Fenbendazole. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for this population. It is recommended that healthcare providers exercise caution when prescribing Fenbendazole to patients with compromised liver function, given the lack of data on its safety and efficacy in this group. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not outlined in the prescribing information.
Overdosage
There is currently no specific information available regarding overdosage for this medication. In the absence of documented overdosage data, healthcare professionals are advised to exercise caution and monitor patients closely for any unusual symptoms or adverse effects that may arise following administration.
In the event of suspected overdosage, it is recommended that healthcare providers initiate supportive care and symptomatic treatment as necessary. Continuous monitoring of vital signs and clinical status is essential. If symptoms of overdosage are observed, appropriate interventions should be implemented based on the clinical presentation.
Healthcare professionals should also consider contacting a poison control center or a medical toxicologist for guidance on management strategies tailored to the specific situation.
Nonclinical Toxicology
No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.
Postmarketing Experience
No postmarketing experience details are available in the insert text.
Patient Counseling
Advise patients that there are no specific patient counseling details provided in the insert text. Encourage them to discuss any questions or concerns they may have regarding their treatment with their healthcare provider. It is important for patients to understand the purpose of their medication, potential side effects, and any necessary precautions they should take while undergoing treatment. Remind patients to report any unusual symptoms or reactions they experience during their therapy.
Storage and Handling
The product is supplied in a container that must be stored in a cool, dry place. It is essential to protect the product from light exposure to maintain its integrity. The container should be kept tightly closed when not in use to prevent contamination and degradation. Freezing the product is not recommended, as it may compromise its quality. Any unused portion should be discarded after opening to ensure safety and efficacy.
Additional Clinical Information
No further data are available.
Drug Information (PDF)
This document includes the full labeling information for Fenbendazole, as submitted by AMGIS LIFESCIENCE LIMITED for veterinary use. It may include dosage by species, withdrawal periods, and administration instructions.